Risk of bisphosphonate-related osteonecrosis of the jaw in implants vs. extractions: a nationwide population-based study

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Clinical Oral Investigations

• Publication date

  2025-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00784-025-06430-1PMID 40601138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No increased risk of osteonecrosis of the jaw in osteoporotic patients with dental implants: a nationwide cohort study

  2024cited by this paper
• Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview

  2023cited by this paper
• Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis

  2023cited by this paper
• American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.

  2022influential reference
• Assessment of clinical guidelines for medication-related osteonecrosis of the jaw: current status and future directions.

  2022cited by this paper
• The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis

  2022cited by this paper
• Preventing or Controlling Periodontitis Reduces the Occurrence of Osteonecrosis of the Jaw (ONJ) in Rice Rats (Oryzomys palustris).

  2021cited by this paper
• Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw

  2021cited by this paper
• Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.

  2021influential reference
• Preclinical Models of Medication-related Osteonecrosis of the Jaw (MRONJ).

  2021cited by this paper
• The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction

  2020cited by this paper
• Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study.

  2020influential reference
• Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.

  2019cited by this paper
• Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.

  2019cited by this paper
• The effect of antiresorptive drugs on implant therapy: Systematic review and meta‐analysis

  2018cited by this paper
• Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study.

  2018cited by this paper
• Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis

  2017cited by this paper
• Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review

  2016cited by this paper
• Managing Osteoporosis in Patients on Long‐Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

  2016influential reference
• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

  2015influential reference
• Infection and Medication-related Osteonecrosis of the Jaw

  2015cited by this paper
• A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis

  2015cited by this paper
• Pathophysiology of Osteonecrosis of the Jaws.

  2015cited by this paper
• The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population

  2015cited by this paper
• Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population

  2014cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

  2014cited by this paper
• American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

  2014cited by this paper
• A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality

  2014cited by this paper
• Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.

  2012cited by this paper
• Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.

  2012cited by this paper
• Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience.

  2012cited by this paper
• Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat

  2011cited by this paper
• Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.

  2010cited by this paper
• Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

  2009cited by this paper
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

  2007influential reference
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

  2007cited by this paper
• The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

  2006cited by this paper
• Publisher's Note

  2003cited by this paper
• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  2003cited by this paper
• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

  2000cited by this paper
• Bisphosphonates: mechanisms of action

  1998cited by this paper

• Vascular and Lymphatic Dysregulation via Non-EndoMT Col2a1 Signaling in Bisphosphonate-Related Osteonecrosis of the Jaw

  2025cites this paper
• A scientometric study on research trends and characteristics of medication-related osteonecrosis of the jaw

  2025cites this paper
• Comparative Evaluation of DMF Scores in Patients Using Bisphosphonates: A Retrospective Study

  2025cites this paper